Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Denufosol tetrasodium

EU orphan designation number: EU/3/05/342   
Active ingredient: Denufosol tetrasodium
Indication: Treatment of cystic fibrosis
Sponsor: Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/12/2005 Orphan Designation EMEA/OD/072/05 (2005)5973 of 23/12/2005
17/05/2007 Transfer of orphan designation EMEA/OD/072/05/T/01 (2007)2189 of 15/05/2007
01/02/2013 Transfer of orphan designation EMA/OD/072/05/T/02 (2013)597 of 30/01/2013